Product Information
RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6560 per EA under NDC 59651084918. Its NADAC has been published 65 times since May 28, 2025.
FDA first approved this application on Apr 10, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651084918
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA208544FDA Approved
4/10/2025
TE Code
AB
On Market Since
4/10/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 65 times since May 28, 2025, and over the history we have for it it has declined 85.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6560 per EA |
|---|---|
| All-time high | $4.6446 (Aug 13, 2025) |
| All-time low | $0.6560 (Aug 19, 2026) |
| 52-week high | $4.3594 |
| 52-week low | $0.6560 |
| Median price | $1.4044 |
| Average price | $2.1602 |
| Largest weekly change | -32.4% (Nov 19, 2025) |
| Weeks tracked | 65 |
| Tracking since | May 28, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6560 per EA (NDC 59651084918), effective Aug 19, 2026.
How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 85.0%. It has been tracked across 65 weekly CMS publications since May 28, 2025.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?
Since May 28, 2025, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.6560 (Aug 19, 2026) to a high of $4.6446 (Aug 13, 2025), with a median of $1.4044 per EA.
Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVAROXABAN 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RIVAROXABAN 2.5 MG TABLET?
RIVAROXABAN 2.5 MG TABLET (NDC 59651084918) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.